Advertisement

Index by author

January 01 1999; volume 48 issue 1

A

  1. Agius, L

    1. Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin.
      S Aiston and L Agius
      Diabetes 1999 Jan; 48 (1): 15-20. https://doi.org/10.2337/diabetes.48.1.15

  2. Ahrén, B

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  3. Aiston, S

    1. Leptin enhances glycogen storage in hepatocytes by inhibition of phosphorylase and exerts an additive effect with insulin.
      S Aiston and L Agius
      Diabetes 1999 Jan; 48 (1): 15-20. https://doi.org/10.2337/diabetes.48.1.15

  4. Alm, P

    1. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
      R Henningsson, P Alm, P Ekström and I Lundquist
      Diabetes 1999 Jan; 48 (1): 66-76. https://doi.org/10.2337/diabetes.48.1.66

  5. Anai, M

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  6. Arner, P

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  7. Asano, T

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  8. Avogaro, A

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

B

  1. Badenhoop, K

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

  2. Barucci, N

    1. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.
      B M Jucker, G W Cline, N Barucci and G I Shulman
      Diabetes 1999 Jan; 48 (1): 134-140. https://doi.org/10.2337/diabetes.48.1.134

  3. Barzilai, N

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  4. Baur, L A

    1. Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition.
      L A Baur, J O'Connor, D A Pan and L H Storlien
      Diabetes 1999 Jan; 48 (1): 112-116. https://doi.org/10.2337/diabetes.48.1.112

  5. Baynes, J W

    1. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
      J W Baynes and S R Thorpe
      Diabetes 1999 Jan; 48 (1): 1-9. https://doi.org/10.2337/diabetes.48.1.1

  6. Beisswenger, P J

    1. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
      P J Beisswenger, S K Howell, A D Touchette, S Lal and B S Szwergold
      Diabetes 1999 Jan; 48 (1): 198-202. https://doi.org/10.2337/diabetes.48.1.198

  7. Berger, D

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

  8. Bieg, S

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  9. Blankenhorn, E P

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  10. Bleackley, R C

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

  11. Bloom, S R

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  12. Blumberg, M

    1. Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia.
      R J Jacob, J Dziura, M Blumberg, J P Morgen and R S Sherwin
      Diabetes 1999 Jan; 48 (1): 141-145. https://doi.org/10.2337/diabetes.48.1.141

  13. Bogardus, C

    1. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians.
      P Schrauwen, J Xia, C Bogardus, R E Pratley and E Ravussin
      Diabetes 1999 Jan; 48 (1): 146-149. https://doi.org/10.2337/diabetes.48.1.146

  14. Boutin, P

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  15. Bouwens, L

    1. Contribution of ductal cells to cytokine responses by human pancreatic islets.
      D Pavlovic, M C Chen, L Bouwens, D L Eizirik and D Pipeleers
      Diabetes 1999 Jan; 48 (1): 29-33. https://doi.org/10.2337/diabetes.48.1.29

  16. Brabant, G

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

  17. Brevi, M

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  18. Bruttomesso, D

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  19. Burns, J

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

C

  1. Cambien, F

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  2. Carallo, C

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  3. Carlsson, A

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  4. Cavallaro, U

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  5. Charron, M J

    1. Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment.
      T P Combatsiaris and M J Charron
      Diabetes 1999 Jan; 48 (1): 128-133. https://doi.org/10.2337/diabetes.48.1.128

  6. Chen, M C

    1. Contribution of ductal cells to cytokine responses by human pancreatic islets.
      D Pavlovic, M C Chen, L Bouwens, D L Eizirik and D Pipeleers
      Diabetes 1999 Jan; 48 (1): 29-33. https://doi.org/10.2337/diabetes.48.1.29

  7. Chung, W

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  8. Clement, K

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  9. Cline, G W

    1. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.
      B M Jucker, G W Cline, N Barucci and G I Shulman
      Diabetes 1999 Jan; 48 (1): 134-140. https://doi.org/10.2337/diabetes.48.1.134

  10. Cohen, P

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  11. Combatsiaris, T P

    1. Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment.
      T P Combatsiaris and M J Charron
      Diabetes 1999 Jan; 48 (1): 128-133. https://doi.org/10.2337/diabetes.48.1.128

  12. Crescenzo, A

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  13. Crozier, A

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

D

  1. Davalli, A M

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  2. De Franceschi, M S

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  3. Degerman, E

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  4. Del Prato, S

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  5. Dietsch, G

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  6. Donner, H

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

  7. Dubois, S

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  8. Dziura, J

    1. Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia.
      R J Jacob, J Dziura, M Blumberg, J P Morgen and R S Sherwin
      Diabetes 1999 Jan; 48 (1): 141-145. https://doi.org/10.2337/diabetes.48.1.141

E

  1. Eckel, R H

    1. Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA.
      I R Schlaepfer and R H Eckel
      Diabetes 1999 Jan; 48 (1): 223-227. https://doi.org/10.2337/diabetes.48.1.223

  2. Edwards, C M

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  3. Ehrnström, B O

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  4. Eizirik, D L

    1. Contribution of ductal cells to cytokine responses by human pancreatic islets.
      D Pavlovic, M C Chen, L Bouwens, D L Eizirik and D Pipeleers
      Diabetes 1999 Jan; 48 (1): 29-33. https://doi.org/10.2337/diabetes.48.1.29

  5. Ekström, P

    1. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
      R Henningsson, P Alm, P Ekström and I Lundquist
      Diabetes 1999 Jan; 48 (1): 66-76. https://doi.org/10.2337/diabetes.48.1.66

  6. Elliott, J F

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

F

  1. Feingold, K R

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  2. Forsblom, C

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  3. Forsén, B

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  4. Freschi, M

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  5. Froguel, P

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  6. Fukushima, Y

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  7. Fuller, J

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  8. Funaki, M

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

G

  1. Ghatei, M A

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  2. Gnasso, A

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  3. Graham, J

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  4. Greenbaum, C J

    1. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
      C J Greenbaum, K L Sears, S E Kahn and J P Palmer
      Diabetes 1999 Jan; 48 (1): 170-175. https://doi.org/10.2337/diabetes.48.1.170

  5. Greiner, D L

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  6. Groop, L C

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  7. Gross, K

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  8. Grunfeld, C

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  9. Guy-Grand, B

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

H

  1. Henningsson, R

    1. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
      R Henningsson, P Alm, P Ekström and I Lundquist
      Diabetes 1999 Jan; 48 (1): 66-76. https://doi.org/10.2337/diabetes.48.1.66

  2. Heringlake, S

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

  3. Herrmann, S M

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  4. Herwig, J

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

  5. Hjorth, P

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  6. Hoffstedt, J

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  7. Holm, C

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  8. Holmäng, A

    1. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.
      A Holmäng, C Nilsson, M Niklasson, B M Larsson and P Lönroth
      Diabetes 1999 Jan; 48 (1): 106-111. https://doi.org/10.2337/diabetes.48.1.106

  9. Holst, L S

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  10. Honjyo, H

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

  11. Howell, S K

    1. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
      P J Beisswenger, S K Howell, A D Touchette, S Lal and B S Szwergold
      Diabetes 1999 Jan; 48 (1): 198-202. https://doi.org/10.2337/diabetes.48.1.198

  12. Hunsmann, G

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

I

  1. Inukai, K

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  2. Irace, C

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  3. Isomaa, B

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

J

  1. Jacob, R J

    1. Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia.
      R J Jacob, J Dziura, M Blumberg, J P Morgen and R S Sherwin
      Diabetes 1999 Jan; 48 (1): 141-145. https://doi.org/10.2337/diabetes.48.1.141

  2. Jaeckel, E

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

  3. Jensen, M D

    1. Insulin regulation of regional free fatty acid metabolism.
      S E Meek, K S Nair and M D Jensen
      Diabetes 1999 Jan; 48 (1): 10-14. https://doi.org/10.2337/diabetes.48.1.10

  4. Jiang, J

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  5. Jucker, B M

    1. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.
      B M Jucker, G W Cline, N Barucci and G I Shulman
      Diabetes 1999 Jan; 48 (1): 134-140. https://doi.org/10.2337/diabetes.48.1.134

  6. Jun, H S

    1. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
      H S Jun, P Santamaria, H W Lim, M L Zhang and J W Yoon
      Diabetes 1999 Jan; 48 (1): 34-42. https://doi.org/10.2337/diabetes.48.1.34

K

  1. Kahn, S E

    1. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
      C J Greenbaum, K L Sears, S E Kahn and J P Palmer
      Diabetes 1999 Jan; 48 (1): 170-175. https://doi.org/10.2337/diabetes.48.1.170

  2. Kanda, A

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  3. Kelly, I

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

  4. Kikuchi, M

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  5. Kogure, A

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

  6. Kondo, M

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

  7. Kumar, U

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  8. Kurth, R

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

L

  1. Lahti, K

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  2. Lal, S

    1. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
      P J Beisswenger, S K Howell, A D Touchette, S Lal and B S Szwergold
      Diabetes 1999 Jan; 48 (1): 198-202. https://doi.org/10.2337/diabetes.48.1.198

  3. Larsson, B M

    1. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.
      A Holmäng, C Nilsson, M Niklasson, B M Larsson and P Lönroth
      Diabetes 1999 Jan; 48 (1): 106-111. https://doi.org/10.2337/diabetes.48.1.106

  4. Lean, M E

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

  5. Ledet, T

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  6. Lee, E S

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  7. Leibel, R

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  8. Leif, J

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  9. Lepretre, F

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  10. Lernmark, A

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  11. Li, H

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  12. Lim, H W

    1. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
      H S Jun, P Santamaria, H W Lim, M L Zhang and J W Yoon
      Diabetes 1999 Jan; 48 (1): 34-42. https://doi.org/10.2337/diabetes.48.1.34

  13. Liu, B Q

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  14. Lönnqvist, F

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  15. Lönroth, P

    1. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.
      A Holmäng, C Nilsson, M Niklasson, B M Larsson and P Lönroth
      Diabetes 1999 Jan; 48 (1): 106-111. https://doi.org/10.2337/diabetes.48.1.106

  16. Lundquist, I

    1. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
      R Henningsson, P Alm, P Ekström and I Lundquist
      Diabetes 1999 Jan; 48 (1): 66-76. https://doi.org/10.2337/diabetes.48.1.66

M

  1. Mahmoudi, M

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  2. Manns, M P

    1. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM.
      E Jaeckel, S Heringlake, D Berger, G Brabant, G Hunsmann and M P Manns
      Diabetes 1999 Jan; 48 (1): 209-214. https://doi.org/10.2337/diabetes.48.1.209

  3. Marescotti, M C

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  4. Mari, A

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  5. Marron, M P

    1. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes.
      A Muir, Q G Ruan, M P Marron and J X She
      Diabetes 1999 Jan; 48 (1): 219-222. https://doi.org/10.2337/diabetes.48.1.219

  6. Martin, A M

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  7. Mattioli, P L

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  8. Maxson, M N

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  9. Meek, S E

    1. Insulin regulation of regional free fatty acid metabolism.
      S E Meek, K S Nair and M D Jensen
      Diabetes 1999 Jan; 48 (1): 10-14. https://doi.org/10.2337/diabetes.48.1.10

  10. Memon, R A

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  11. Metrakos, P

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  12. Miettinen, A

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  13. Mordes, J P

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50

  14. Morgen, J P

    1. Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia.
      R J Jacob, J Dziura, M Blumberg, J P Morgen and R S Sherwin
      Diabetes 1999 Jan; 48 (1): 141-145. https://doi.org/10.2337/diabetes.48.1.141

  15. Moser, A H

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  16. Motti, C

    1. NIDDM is associated with lower wall shear stress of the common carotid artery.
      C Irace, C Carallo, A Crescenzo, C Motti, M S De Franceschi, P L Mattioli and A Gnasso
      Diabetes 1999 Jan; 48 (1): 193-197. https://doi.org/10.2337/diabetes.48.1.193

  17. Muir, A

    1. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes.
      A Muir, Q G Ruan, M P Marron and J X She
      Diabetes 1999 Jan; 48 (1): 219-222. https://doi.org/10.2337/diabetes.48.1.219

  18. Mulder, H

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

N

  1. Nair, K S

    1. Insulin regulation of regional free fatty acid metabolism.
      S E Meek, K S Nair and M D Jensen
      Diabetes 1999 Jan; 48 (1): 10-14. https://doi.org/10.2337/diabetes.48.1.10

  2. Nawano, M

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  3. Neumann, J

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

  4. Nielsen, A H

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  5. Nielsen, C B

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  6. Niklasson, M

    1. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.
      A Holmäng, C Nilsson, M Niklasson, B M Larsson and P Lönroth
      Diabetes 1999 Jan; 48 (1): 106-111. https://doi.org/10.2337/diabetes.48.1.106

  7. Nilsson, A

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  8. Nilsson, C

    1. Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin.
      A Holmäng, C Nilsson, M Niklasson, B M Larsson and P Lönroth
      Diabetes 1999 Jan; 48 (1): 106-111. https://doi.org/10.2337/diabetes.48.1.106

  9. Nissén, M

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  10. Noroozi, M

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

O

  1. O'Connor, J

    1. Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition.
      L A Baur, J O'Connor, D A Pan and L H Storlien
      Diabetes 1999 Jan; 48 (1): 112-116. https://doi.org/10.2337/diabetes.48.1.112

  2. Ogihara, T

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  3. Oka, Y

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  4. Onishi, Y

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  5. Otabe, S

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

P

  1. Palmer, J P

    1. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
      C J Greenbaum, K L Sears, S E Kahn and J P Palmer
      Diabetes 1999 Jan; 48 (1): 170-175. https://doi.org/10.2337/diabetes.48.1.170

  2. Pan, D A

    1. Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition.
      L A Baur, J O'Connor, D A Pan and L H Storlien
      Diabetes 1999 Jan; 48 (1): 112-116. https://doi.org/10.2337/diabetes.48.1.112

  3. Parlow, A F

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  4. Patel, A

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  5. Patel, S C

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  6. Patel, Y C

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  7. Pavlovic, D

    1. Contribution of ductal cells to cytokine responses by human pancreatic islets.
      D Pavlovic, M C Chen, L Bouwens, D L Eizirik and D Pipeleers
      Diabetes 1999 Jan; 48 (1): 29-33. https://doi.org/10.2337/diabetes.48.1.29

  8. Pelloux, V

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  9. Peterman, G

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  10. Pianta, A

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  11. Pipeleers, D

    1. Contribution of ductal cells to cytokine responses by human pancreatic islets.
      D Pavlovic, M C Chen, L Bouwens, D L Eizirik and D Pipeleers
      Diabetes 1999 Jan; 48 (1): 29-33. https://doi.org/10.2337/diabetes.48.1.29

  12. Poirier, O

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  13. Pontiroli, A E

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  14. Pratley, R E

    1. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians.
      P Schrauwen, J Xia, C Bogardus, R E Pratley and E Ravussin
      Diabetes 1999 Jan; 48 (1): 146-149. https://doi.org/10.2337/diabetes.48.1.146

R

  1. Rabinovitch, A

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

  2. Rajotte, R V

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

  3. Rasmussen, L M

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  4. Ravussin, E

    1. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians.
      P Schrauwen, J Xia, C Bogardus, R E Pratley and E Ravussin
      Diabetes 1999 Jan; 48 (1): 146-149. https://doi.org/10.2337/diabetes.48.1.146

  5. Rorsman, P

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  6. Rossetti, L

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  7. Ruan, Q G

    1. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes.
      A Muir, Q G Ruan, M P Marron and J X She
      Diabetes 1999 Jan; 48 (1): 219-222. https://doi.org/10.2337/diabetes.48.1.219

S

  1. Sakane, N

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

  2. Sakoda, H

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  3. Saloranta, C

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  4. Santamaria, P

    1. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
      H S Jun, P Santamaria, H W Lim, M L Zhang and J W Yoon
      Diabetes 1999 Jan; 48 (1): 34-42. https://doi.org/10.2337/diabetes.48.1.34

  5. Sanvito, F

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  6. Sarvetnick, N

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

  7. Sasi, R

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  8. Sattar, N

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

  9. Scaglia, L

    1. Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts.
      A M Davalli, L Scaglia, M Brevi, F Sanvito, M Freschi, U Cavallaro, A F Parlow and A E Pontiroli
      Diabetes 1999 Jan; 48 (1): 59-65. https://doi.org/10.2337/diabetes.48.1.59

  10. Schimpf, B

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  11. Schlaepfer, I R

    1. Plasma triglyceride reduction in mice after direct injections of muscle-specific lipoprotein lipase DNA.
      I R Schlaepfer and R H Eckel
      Diabetes 1999 Jan; 48 (1): 223-227. https://doi.org/10.2337/diabetes.48.1.223

  12. Schrauwen, P

    1. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians.
      P Schrauwen, J Xia, C Bogardus, R E Pratley and E Ravussin
      Diabetes 1999 Jan; 48 (1): 146-149. https://doi.org/10.2337/diabetes.48.1.146

  13. Sears, K L

    1. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
      C J Greenbaum, K L Sears, S E Kahn and J P Palmer
      Diabetes 1999 Jan; 48 (1): 170-175. https://doi.org/10.2337/diabetes.48.1.170

  14. She, J X

    1. The IDDMK(1,2)22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes.
      A Muir, Q G Ruan, M P Marron and J X She
      Diabetes 1999 Jan; 48 (1): 219-222. https://doi.org/10.2337/diabetes.48.1.219

  15. She, L

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  16. Sherwin, R S

    1. Effects of recurrent hypoglycemia on brainstem function in diabetic BB rats: protective adaptation during acute hypoglycemia.
      R J Jacob, J Dziura, M Blumberg, J P Morgen and R S Sherwin
      Diabetes 1999 Jan; 48 (1): 141-145. https://doi.org/10.2337/diabetes.48.1.141

  17. Shulman, G I

    1. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study.
      B M Jucker, G W Cline, N Barucci and G I Shulman
      Diabetes 1999 Jan; 48 (1): 134-140. https://doi.org/10.2337/diabetes.48.1.134

  18. Simonson, W T

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  19. Smith, P J

    1. Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice.
      R A Memon, J Fuller, A H Moser, P J Smith, C Grunfeld and K R Feingold
      Diabetes 1999 Jan; 48 (1): 121-127. https://doi.org/10.2337/diabetes.48.1.121

  20. Snickars, B

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  21. Sorensen, O

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

  22. Storlien, L H

    1. Relationships between maternal risk of insulin resistance and the child's muscle membrane fatty acid composition.
      L A Baur, J O'Connor, D A Pan and L H Storlien
      Diabetes 1999 Jan; 48 (1): 112-116. https://doi.org/10.2337/diabetes.48.1.112

  23. Suarez-Pinzon, W

    1. Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets.
      W Suarez-Pinzon, O Sorensen, R C Bleackley, J F Elliott, R V Rajotte and A Rabinovitch
      Diabetes 1999 Jan; 48 (1): 21-28. https://doi.org/10.2337/diabetes.48.1.21

  24. Sund, G C

    1. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat.
      E S Lee, J Jiang, G C Sund, W T Simonson, J Graham, G Dietsch, B Schimpf, S Bieg, G Peterman and A Lernmark
      Diabetes 1999 Jan; 48 (1): 43-49. https://doi.org/10.2337/diabetes.48.1.43

  25. Sundler, F

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  26. Suresh, S

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  27. Svensson, H

    1. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells.
      H Mulder, L S Holst, H Svensson, E Degerman, F Sundler, B Ahrén, P Rorsman and C Holm
      Diabetes 1999 Jan; 48 (1): 228-232. https://doi.org/10.2337/diabetes.48.1.228

  28. Szwergold, B S

    1. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
      P J Beisswenger, S K Howell, A D Touchette, S Lal and B S Szwergold
      Diabetes 1999 Jan; 48 (1): 198-202. https://doi.org/10.2337/diabetes.48.1.198

T

  1. Talwar, D

    1. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA.
      M E Lean, M Noroozi, I Kelly, J Burns, D Talwar, N Sattar and A Crozier
      Diabetes 1999 Jan; 48 (1): 176-181. https://doi.org/10.2337/diabetes.48.1.176

  2. Taskinen, M R

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

  3. Thangaraju, M

    1. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
      U Kumar, R Sasi, S Suresh, A Patel, M Thangaraju, P Metrakos, S C Patel and Y C Patel
      Diabetes 1999 Jan; 48 (1): 77-85. https://doi.org/10.2337/diabetes.48.1.77

  4. Thörne, A

    1. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.
      J Hoffstedt, O Poirier, A Thörne, F Lönnqvist, S M Herrmann, F Cambien and P Arner
      Diabetes 1999 Jan; 48 (1): 203-205. https://doi.org/10.2337/diabetes.48.1.203

  5. Thorpe, S R

    1. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
      J W Baynes and S R Thorpe
      Diabetes 1999 Jan; 48 (1): 1-9. https://doi.org/10.2337/diabetes.48.1.1

  6. Tiengo, A

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  7. Todd, J F

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  8. Tönjes, R R

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

  9. Touchette, A D

    1. Metformin reduces systemic methylglyoxal levels in type 2 diabetes.
      P J Beisswenger, S K Howell, A D Touchette, S Lal and B S Szwergold
      Diabetes 1999 Jan; 48 (1): 198-202. https://doi.org/10.2337/diabetes.48.1.198

  10. Tuomi, T

    1. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
      T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars, K Lahti, C Forsblom, C Saloranta, M R Taskinen and L C Groop
      Diabetes 1999 Jan; 48 (1): 150-157. https://doi.org/10.2337/diabetes.48.1.150

U

  1. Umekawa, T

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

  2. Usadel, K H

    1. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
      K Badenhoop, H Donner, J Neumann, J Herwig, R Kurth, K H Usadel and R R Tönjes
      Diabetes 1999 Jan; 48 (1): 215-218. https://doi.org/10.2337/diabetes.48.1.215

V

  1. Valerio, A

    1. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
      D Bruttomesso, A Pianta, A Mari, A Valerio, M C Marescotti, A Avogaro, A Tiengo and S Del Prato
      Diabetes 1999 Jan; 48 (1): 99-105. https://doi.org/10.2337/diabetes.48.1.99

  2. Vasseur, F

    1. Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients.
      S Otabe, K Clement, S Dubois, F Lepretre, V Pelloux, R Leibel, W Chung, P Boutin, B Guy-Grand, P Froguel and F Vasseur
      Diabetes 1999 Jan; 48 (1): 206-208.

  3. Vuguin, P

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

W

  1. Wang, J

    1. Surgical removal of visceral fat reverses hepatic insulin resistance.
      N Barzilai, L She, B Q Liu, P Vuguin, P Cohen, J Wang and L Rossetti
      Diabetes 1999 Jan; 48 (1): 94-98. https://doi.org/10.2337/diabetes.48.1.94

  2. Wang, R M

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  3. Wang, Z

    1. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39.
      C M Edwards, J F Todd, M Mahmoudi, Z Wang, R M Wang, M A Ghatei and S R Bloom
      Diabetes 1999 Jan; 48 (1): 86-93. https://doi.org/10.2337/diabetes.48.1.86

  4. Wogensen, L

    1. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice.
      L Wogensen, C B Nielsen, P Hjorth, L M Rasmussen, A H Nielsen, K Gross, N Sarvetnick and T Ledet
      Diabetes 1999 Jan; 48 (1): 182-192. https://doi.org/10.2337/diabetes.48.1.182

X

  1. Xia, J

    1. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians.
      P Schrauwen, J Xia, C Bogardus, R E Pratley and E Ravussin
      Diabetes 1999 Jan; 48 (1): 146-149. https://doi.org/10.2337/diabetes.48.1.146

Y

  1. Yazaki, Y

    1. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.
      M Anai, M Funaki, T Ogihara, A Kanda, Y Onishi, H Sakoda, K Inukai, M Nawano, Y Fukushima, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jan; 48 (1): 158-169. https://doi.org/10.2337/diabetes.48.1.158

  2. Yoon, J W

    1. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
      H S Jun, P Santamaria, H W Lim, M L Zhang and J W Yoon
      Diabetes 1999 Jan; 48 (1): 34-42. https://doi.org/10.2337/diabetes.48.1.34

  3. Yoshida, T

    1. Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.
      T Umekawa, T Yoshida, N Sakane, A Kogure, M Kondo and H Honjyo
      Diabetes 1999 Jan; 48 (1): 117-120. https://doi.org/10.2337/diabetes.48.1.117

Z

  1. Zhang, M L

    1. Absolute requirement of macrophages for the development and activation of beta-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice.
      H S Jun, P Santamaria, H W Lim, M L Zhang and J W Yoon
      Diabetes 1999 Jan; 48 (1): 34-42. https://doi.org/10.2337/diabetes.48.1.34

  2. Zhao, M

    1. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat.
      A M Martin, E P Blankenhorn, M N Maxson, M Zhao, J Leif, J P Mordes and D L Greiner
      Diabetes 1999 Jan; 48 (1): 50-58. https://doi.org/10.2337/diabetes.48.1.50
Back to top